EV-B 3D polymerase remodels viral populations through 5′UTR recombination to subvert cardiac antiviral innate immunity
PLOS Pathogens · 24.07.2026 · 22 (7) · e1014441
DOI: 10.1371/journal.ppat.1014441 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 24.07.2026. Verfasst von Marie Glenet und 6 weiteren Autor:innen. Beteiligte Einrichtung: Inserm, UMR-S1320 CardioVir, University of Reims Champagne Ardennes, Reims, France. Hauptthemen laut MEDLINE: Immunity, Innate, 5' Untranslated Regions, Enterovirus B, Human, Coxsackievirus Infections. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French Cardiology Federation (FFC), University of Reims Champagne-Ardenne (URCA), INSERM Grand-Est.
Abstract (Originalsprache)
Viral myocarditis, a leading cause of morbidity in young populations, is strongly linked to Coxsackievirus B (CV-B) infections harboring dominant 5′-terminally deleted (5′TD) and minor full-length (FL) CV-B RNA populations in cardiac tissues. Here, we demonstrate how viral RNA-dependent RNA polymerase (3Dpol)-driven recombination in the 5′UTR orchestrates viral RNA populations dynamics and subverts type I interferon responses. In primary human cardiomyocytes (HCMs), 3Dpol-mediated copy-choice recombination enhances 5′TD RNA replication while suppressing FL populations. Infection of immunocompetent mice with recombination-deficient CV-B3 (3Dpol Y276H) shifted 5′TD populations ratios toward immune-sensing viral RNAs, elevating cardiac IFN-β/ISG15 and accelerating viral clearance. Transfection experiments confirmed that 50-nt 5′TD RNAs (TD50) evade innate immunity, whereas shorter deletions (9–36-nt, TD15) restore type I interferon responses in HCMs. Our findings establish 3Dpol-driven recombination as a critical mechanism sustaining pathogenic 5′TD RNAs that subvert antiviral innate immunity, highlighting recombination inhibition as a promising therapeutic strategy against CV-B myocarditis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Inserm, UMR-S1320 CardioVir, University of Reims Champagne Ardennes, Reims, France.
- Infectious Diseases Department, Academic Hospital of Reims, Robert Debré, Reims, France.
- Medical Virology Department, Academic Hospital of Reims, Robert Debré, Reims, France.
ORCID-Profile: Laurent Andreoletti
Förderung
- French Cardiology Federation (FFC)
- University of Reims Champagne-Ardenne (URCA)
- INSERM Grand-Est
Zitieren
APA
Glenet, M., Heng, L., Lebreil, A. L., Gretteau, P. A., Nguyen, Y., Berri, F., & Andreoletti, L. (2026). EV-B 3D polymerase remodels viral populations through 5′UTR recombination to subvert cardiac antiviral innate immunity. PLOS Pathogens, 22(7), e1014441. https://doi.org/10.1371/journal.ppat.1014441
Vancouver
Glenet M, Heng L, Lebreil AL, Gretteau PA, Nguyen Y, Berri F, et al. EV-B 3D polymerase remodels viral populations through 5′UTR recombination to subvert cardiac antiviral innate immunity. PLOS Pathogens. 2026;22(7):e1014441. doi:10.1371/journal.ppat.1014441
BibTeX
@article{Glenet2026,
author = {Glenet, Marie and Heng, Laetitia and Lebreil, Anne-Laure and Gretteau, Paul-Antoine and Nguyen, Yohan and Berri, Fatma and Andreoletti, Laurent},
title = {EV-B 3D polymerase remodels viral populations through 5′UTR recombination to subvert cardiac antiviral innate immunity},
journal = {PLOS Pathogens},
year = {2026},
volume = {22},
number = {7},
pages = {e1014441},
doi = {10.1371/journal.ppat.1014441}
}
EUVIMED